Inogen, Inc. (FRA:6IO)

Market Cap	165.76M
Revenue (ttm)	295.77M
Net Income (ttm)	-21.63M
Shares Out	n/a
EPS (ttm)	-0.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	318
Open	6.05
Previous Close	6.10
Day's Range	6.05 - 6.05
52-Week Range	5.05 - 11.90
Beta	n/a
RSI	42.25
Earnings Date	Feb 25, 2026

About Inogen

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related a...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2001
• Employees: 766
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6IO

Financial Performance

In 2024, Inogen's revenue was $335.71 million, an increase of 6.35% compared to the previous year's $315.66 million. Losses were -$35.89 million, -64.97% less than in 2023.

Financial numbers in USD